Navigation Links
Allscripts announces first quarter 2013 results
Date:5/9/2013

ion and GAAP loss per share was $0.07.  This compares with net income of $5.8 million and diluted earnings per share of $0.03 in the first quarter of 2012.
  • Non-GAAP net income, after adjustments for certain non-recurring expenses and transaction-related costs, was $16.2 million resulting in non-GAAP diluted earnings per share of $0.09.  This compares with $23.5 million and $0.12, respectively, in the first quarter of 2012.
  • Adjusted EBITDA was $49.8 million for three months ended March 31, 2013, or 14 percent of total non-GAAP revenue.  This compares with $58.3 million or 16 percent of non-GAAP revenue for the prior-year period.
  • First quarter 2013 GAAP results include the following items, all on a pre-tax basis:
  • Acquisition-related deferred-revenue adjustment of $0.9 million.
  • Acquisition-related amortization expense of $16.2 million.
  • Stock-based compensation expense of $8.0 million.
  • Non-recurring expenses and transaction-related costs totaled $20.8 and consist of the following:
  • severance and other costs primarily associated with site consolidation totaling $12.6 million;
  • MyWay™  product consolidation costs of $6.2 million;
  • Transaction-related costs of $2.0 million related to the acquisitions of dbMotion and Jardogs. 
  • Please refer to the Explanation of Non-GAAP Financial Measures section in this news release for further discussion of these items.
  • Please refer to Table 4 "Condensed Non-GAAP Financial Information" for a complete reconciliation of all GAAP and non-GAAP financial measures discussed in this news release.Liquidity and CashDuring the first quarter of 2013, Allscripts repaid approximately $18 million of borrowings under its senior secured credit facilities.  In connection with the acquisitions of dbMotion and Jardogs in March 2013, the Company borrowed an additional $120 million under its existing revolving
    '/>"/>

    SOURCE Allscripts Healthcare Solutions, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. Allscripts Adds Two Independent Directors to Board
    2. Developers: Deadline Approaching for Allscripts Million Hearts CDS Challenge
    3. Allscripts Announces Second Quarter 2012 Results
    4. Allscripts and Aprima Settle Legal Matters
    5. Allscripts Announces Third Quarter 2012 Results
    6. Baylor University Medical Center activates Allscripts electronic health record system
    7. Allscripts adopts majority voting policy for directors
    8. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
    9. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
    10. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
    11. Misonix Announces New Distribution Agreement For Panama
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/24/2014)... , July 24, 2014  Alimera Sciences, Inc. ... that specializes in the research, development and commercialization of ... its second quarter of fiscal year 2014 financial results ... An investor conference call will follow on the same ... conference call will be hosted by Dan Myers ...
    (Date:7/24/2014)... 2014 LSI Medience Corporation today announced ... Kineticos, a Raleigh-Durham, NC ... LSI Medience in identifying opportunities for Presepsin, a ... in clinical trials. The Presepsin biomarker ... of sepsis, prognosis of septic patients, early risk ...
    (Date:7/24/2014)... 24, 2014  Perrigo Company (NYSE: PRGO ... AB therapeutic equivalent rating from the U.S. Food and ... Application (NDA) for testosterone gel 1.0%. FDA concluded that ... 1% and can be substituted with the full expectation ... safety profile as AndroGel 1% when used under the ...
    Breaking Medicine Technology:Alimera Sciences To Release Second Quarter 2014 Results 2LSI Medience Corporation and Kineticos Sign Agreement Related to the Presepsin Biomarker in Sepsis Management and Treatment 2Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 2Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 3
    ... evaluate, clinical utility of protein biomarkers for predicting treatment ... ... Conn., Sept. 4 HistoRx, Inc., announced,today that it has ... (RTOG), a National Cancer Institute-funded clinical,cooperative group. Under the terms ...
    ... - ViziLite Plus with TBlue630 -, PHOENIX, Sept. ... with Tblue630(TM) screening system for early detection of,abnormalities which ... identify,pre-cancerous lesions in a Phase II study of Cetuximab ... developed by ImClone,Systems (Nasdaq: IMCL ) and distributed ...
    Cached Medicine Technology:HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership 2HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership 3Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX 2Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX 3
    (Date:7/24/2014)... In a recent report by CBS News, the ... end to criminal penalties associated with possession of small amounts ... reform in Washington DC, giving it one of the most ... penalties for possession of one ounce of marijuana or less ... more than an ounce of marijuana remain criminal offenses under ...
    (Date:7/24/2014)... circumcisions that involves direct oral suction is a likely ... transmissions documented in infants between 1988 and 2012, a ... and published online in the Journal of the ... from Penn,s Center for Evidence-based Practice , identified ... , The practiceknown as metzitzah b,pehand its link to ...
    (Date:7/24/2014)... New research from Penn Medicine shows that incisionless ... of hospital stay by 30 percent and has ... compared with conventional transfemoral TAVR, which requires an ... available in the current issue of Circulation: ... of the aortic valve without a traditional open-heart ...
    (Date:7/24/2014)... Papillomavirus Vaccination (HPV) even after becoming sexually active ... than those who were never vaccinated. These findings ... . , Researchers from Boston University School ... a cross-sectional study of 235 women age 21 ... status and demographic and behavioral characteristics were self-reported ...
    (Date:7/24/2014)... R.I. Lynn E. Taylor, M.D., director of ... in the July, 2014 Rhode Island Medical ... that eliminating hepatitis c virus infection (hep c ... enhance capacity to address other health challenges, and ... in the United States, Taylor says, include lack ...
    Breaking Medicine News(10 mins):Health News:Washington D.C. Decriminalizes Marijuana 2Health News:Link between ritual circumcision procedure and herpes infection in infants examined 2Health News:Penn study: Incisionless transcatheter aortic valve replacement surgery cuts hospital length of stay 2Health News:Miriam Hospital physician advocates awareness, collaboration to combat peaking hep C virus 2Health News:Miriam Hospital physician advocates awareness, collaboration to combat peaking hep C virus 3Health News:Miriam Hospital physician advocates awareness, collaboration to combat peaking hep C virus 4
    ... March 17 Researchers will unveil a,new ... been shown in numerous,published studies to help ... the performance of daily living tasks essential ... Corporation, a San,Francisco-based neuroscience company, will introduce ...
    ... is the Largest Prospective Trial to Examine Asthma Outcomes Based on ... ... N.C. and PHILADELPHIA, March 16 ,Data presented today by GlaxoSmithKline showed ... in asthma patients did not,lead to different responses to Advair Diskus(R) ...
    ... is the daily,"Profile America" feature from the U.S. Census ... Profile America -- Saturday, March 15th. If you,re ... it,s time to pause,stand back and reflect that there ... events celebrating the value of laughter and those who ...
    ... Coronary Heart Disease, WASHINGTON, March 14 ... the decision by the Centers,for Medicare and Medicaid ... coverage,for cardiac computed tomographic angiography (CTA) for the ... its national coverage decision for this important,tool for ...
    ... (March 13, 2008) The American Academy of Cosmetic ... its 2007 Procedural Data. This information is collected by ... that sclerotherapy, the standard treatment for spider and varicose ... surgical procedure, due in large part to men. ...
    ... found it made difference when disease moved from colon, ... certain patients with cancer that has spread to the ... surgery combined with a special kind of chemotherapy can ... The findings are from one of two Wake Forest ...
    Cached Medicine News:Health News:New Brain Fitness Training Promotes Health and Independence of Long Term Care Insurance Policyholders 2Health News:New Brain Fitness Training Promotes Health and Independence of Long Term Care Insurance Policyholders 3Health News:GSK Data Suggests Efficacy of Advair(R) and Serevent(R) is Not Impacted by Genetic Profile 2Health News:GSK Data Suggests Efficacy of Advair(R) and Serevent(R) is Not Impacted by Genetic Profile 3Health News:GSK Data Suggests Efficacy of Advair(R) and Serevent(R) is Not Impacted by Genetic Profile 4Health News:SCAI Applauds CMS Decision to Continue Coverage of Cardiac CT Scans 2Health News:Combo Treatment Ups Survival When Cancer Spreads to Abdominal Lining 2
    ... Our ELISA products for autoimmune testing feature ... as well as specific reflex tests including ... Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 and ... includes a full line of products for ...
    Indirect hemagglutination test for the qualitative and quantitative determination of antibodies to Toxoplasma gondii in serum....
    ... Rapid Plasma Reagin ... rapid detection and quantitative ... serum or plasma. Uses ... to detect reagin. Kits ...
    Latex agglutination slide test for the qualitative and quantitative detection of rubella virus antibody in serum....
    Medicine Products: